Computational Modeling of Nasal Cavity Aerodynamics: Implications for Surgical Outcomes and Targeted Drug Administration.

The primary goal of sinonasal surgery is to improve a patient's quality of life, which is generally achieved by enhancing drug delivery (eg, saline rinses, nasal steroids) and nasal airflow. Both drug delivery and nasal airflow are dependent on the anatomic structure of the sinonasal cavity and the relationship between this anatomy and airflow and drug delivery can be studied using computational fluid dynamics (CFD). CFD generally uses computed tomography scans and computational algorithms to predict airflow or drug delivery and can help us understand surgical outcomes and optimize drug delivery for patients. This study employs CFD to simulate nasal airflow dynamics and optimize drug delivery in the nasal cavity to highlight the utility of CFD for studying sinonasal disease. Utilizing COMSOL Multiphysics software, we developed detailed models to analyze changes in airflow characteristics before and after functional endoscopic sinus surgery, focusing on pressure distribution, velocity profiles, streamline patterns, and heat transfer. This research examines the impact of varying levels of nasal airway obstruction on airflow and heat transfer. In addition, we explore the characteristics of nasal drug delivery by simulating diverse spray parameters, including particle size, spray angle, and velocity. Our comprehensive approach allows for the visualization of drug particle trajectories and deposition patterns, providing crucial insights for enhancing surgical outcomes and improving targeted drug administration. By integrating patient-specific nasal cavity models and considering factors such as airway outlet pressure, this study offers valuable data on pressure cross-sections, flow rate variations, and particle behavior within the nasal passages. The findings of this research can be useful for both surgical planning and the development of more effective nasal drug delivery methods, potentially leading to enhanced clinical outcomes in respiratory treatment.